Our Sponsors and Partners
Evolvence India Life Sciences Fund
Evolvence India Life Sciences Fund is a Mauritius-based Private Equity fund established to provide growth capital to companies operating in the Indian healthcare sector.
EILSF invests in small to mid-sized pharmaceutical, biopharmaceutical, medical device, contract R&D, and healthcare services companies which are either located in India or which derive significant competitive advantage from operations located in India. Examples of investments include providing capital for capacity expansion, development of generic versions of drugs facing patent expiry, domestic and international acquisitions, and for up-grading existing infrastructure to emerge as 'partner of choice' for contract R&D and manufacturing activities.
Exampur
Exotel
Exotel is the emerging market’s leading full stack customer engagement platform and business-focused virtual telecom operator. Incorporated in 2011, Exotel’s cloud-based product suite powers 50 million daily engagements across voice, video, and messaging channels. Exotel powers customer engagement to over 7000 companies in 60+ countries, including India, SE Asia, the Middle East, and Africa. Today, some of the fastest-growing companies in the emerging markets (Ola, Swiggy, Flipkart, GoJek, Byju’s, Urban Company, HDFC Bank, Zomato, Oyo, etc.) manage their customer engagement with Exotel’s suite of a communication APIs, Ameyo’s omnichannel contact centre (merger), and Cogno AI‘s conversational AI platform (acquisition) over the cloud. They’re a $100 million Series D funded company with $60 million in ARR.
Exotel + Ameyo
FarEye
FarEye is a digital logistics platform to efficiently move goods. It empowers organizations with predictive visibility and operational intelligence to achieve on-time deliveries at a reduced cost. FarEye facilitates 10+ million shipments per day across 20+ countries for more than 150+ customers.
Feedback Infrastructure
Feedback Infrastructure is India’s leading integrated infrastructure development company. The Corporate Advisory Division (CAD) of Feedback provides strategic advisory services across various sectors including healthcare, education, construction, water, and materials space.
The healthcare practice at Feedback helps clients in conceptualizing and structuring projects, implementing strategic initiatives, project managing hospitals and improving operational and financial performance. Over the years we have built significant experience and expertise in this field and have worked with most of the leading players in the industry across performance improvement, business diligence, market research, business planning, financial planning, public private partnerships etc.
Illustrative list of clients includes
1. Leading providers: including Max Healthcare, Fortis Healthcare, Wockhardt Hospitals, Apollo Tyres (Artemis), Dr. Lal Path Labs, Elbit Healthcare, Moolchand and Sterling Hospitals etc.;
2. Private equity investors: like Advent International, India Equity Partners, Asian Healthcare Fund, Actis, Arcapita Bank, IDFC etc.
3. State governments: such as Delhi, Goa and Punjab.
Fibe
FidelisWorld
We are a unique investment firm that identifies growth capital investment opportunities in the Indian applied technology, media & entertainment, and lifestyle ecosystem.
We use our proprietary networks to identify excellent entrepreneurs whose companies are profitable; have scalable, high-RoE business models; are sustainable against disruption; and have the potential to develop a global footprint.
We establish true partnerships with management while actively assisting in value creation, thereby generating superior equity returns.
FidelisWorld Group
FidelisWorld is growth focused Private Equity investment firm backing emerging, Indian companies. Since its inception in 2013, FidelisWorld has been helping unique Indian companies expand domestically and diversify revenues internationally. FidelisWorld’s first fund was invested across several companies including the likes of Wildcraft, Sportz Interactive and Technology Frontiers.